Found 10 matching trials
AGILE (Early Phase Platform Trial for COVID-19)
PHASE1The AGILE platform master protocol allows incorporation of a range of ident...
Location
Desmond Tutu Health Foundation
Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study
PHASE1This phase I trial studies the process by which sotrovimab is absorbed, dis...
Location
Fred Hutch/University of Washington Cancer Consortium
Intramuscular and Intravenous VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19.
PHASE3The COMET-TAIL main study evaluated efficacy, safety, and tolerability of I...
Location
Investigative Site
A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness
PHASE2The purpose of this study is to measure how well monoclonal antibodies work...
Location
University of Alabama at Birmingham
ACTIV-3: Therapeutics for Inpatients With COVID-19
PHASE3This study looks at the safety and effectiveness of different drugs in trea...
Location
Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue
VIR-7831 for the Early Treatment of COVID-19 in Outpatients
PHASE2This is a phase 2/3 study in which subjects with coronavirus disease 2019 (...
Location
Investigative Site
VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
PHASE3This study looks at the safety and effectiveness of VIR-7831 in treating CO...
Location
Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue
Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19
PHASE2This is a phase 2 study in which subjects with coronavirus disease 2019 (CO...
Location
Investigative Site
A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals
PHASE2This is an open-label study examining the safety and tolerability of sotrov...
Location
Massachusetts General Hospital
PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V
PHASE2COVID-19 (SARS-CoV2 virus) was declared a global pandemic by the WHO on 11t...
Location
Cambridge University Hospitals NHS Foundation Trust